中國銀保監發布保險資產管理公司監管評級暫行辦法
中國銀保監會發布《保險資產管理公司監管評級暫行辦法》辦法稱,監管評級主要從公司治理與內控、資產管理能力、全面風險管理、交易與運營保障、信息披露等五個維度指標對保險資產管理公司進行綜合評分。
評分採用定性與定量相結合的方式,以「賦分制」打分,滿分為100分,五個維度指標分別為20分、30分、25分、15分和10分。
此外,將明確保險資產管理公司的監管評級周期為一年。根據監管評級結果,將保險資產管理公司劃分為A、B、C、D四類機構,明確分類結果是衡量公司經營管理能力和風險管理能力的主要依據。對於不同類型機構,監管機構將在市場准入、業務範圍、產品創新、現場檢查等方面採取差異化的監管措施。(ta/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.